Report date: Nov 6,2024 Conflict count: 361874 Publisher: Wiley (Blackwell Publishing) Title count: 475 Conflict count: 16773 ========================================================== Created: 2023-10-11 13:53:12 ConfID: 6960727 CauseID: 1592611436 OtherID: 138686763 JT: Clinical Genetics MD: ,65,1,1,2004,The dichotomy of causation vs consequence in ID DOI: 10.1111/j..2004.0195a.x(Journal) (6960727-N) DOI: 10.1111/j..2004.0195b.x(Journal) ========================================================== Created: 2023-10-11 13:58:36 ConfID: 6960912 CauseID: 1592613332 OtherID: 138686326 JT: Clinical Genetics MD: Nasir,63,1,11,2003,Hotspots DOI: 10.1034/j.1399-0004.2002.6105022.x(Journal) (6960912-N) DOI: 10.1034/j.1399-0004.2002.610502.x-i3(Journal) ========================================================== Created: 2023-10-11 13:58:36 ConfID: 6960913 CauseID: 1592613332 OtherID: 138686326 JT: Clinical Genetics MD: Nasir,63,1,13,2003,Hotspots DOI: 10.1034/j.1399-0004.2002.6105023.x(Journal) (6960913-N) DOI: 10.1034/j.1399-0004.2002.620417.x-i1(Journal) ========================================================== Created: 2023-10-15 17:03:42 ConfID: 6961658 CauseID: 1593115137 OtherID: 138685487 JT: Clinical Genetics MD: Hackam,59,3,152,2001,Silencing the quiet DOI: 10.1034/j.1399-0004.2001.590302.2.x(Journal) (6961658-N) DOI: 10.1111/j.1399-0004.2001.590302.2.x(Journal) ========================================================== Created: 2023-10-15 17:03:42 ConfID: 6961659 CauseID: 1593115137 OtherID: 138685487 JT: Clinical Genetics MD: Hackam,59,3,153,2001,A phosphatase mutation implicated in multiple sclerosis DOI: 10.1034/j.1399-0004.2001.590302.3.x(Journal) (6961659-N) DOI: 10.1111/j.1399-0004.2001.590302.3.x(Journal) ========================================================== Created: 2023-10-16 05:09:20 ConfID: 6961729 CauseID: 1593167425 OtherID: 3141 JT: Clinical Genetics MD: Lewis,59,6,389,2001,Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: Production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model DOI: 10.1034/j.1399-0004.2001.590602.3.x(Journal) (6961729-N) DOI: 10.1111/j.1399-0004.2001.590602.3.x(Journal) ========================================================== Created: 2023-10-16 00:59:14 ConfID: 6962648 CauseID: 1593143652 OtherID: 3148 JT: Clinical Genetics MD: Devon,60,2,99,2001,HotSpots DOI: 10.1034/j.1399-0004.2001.600202.1.x(Journal) (6962648-N) DOI: 10.1034/j.1399-0004.2001.6002021.x(Journal) ========================================================== Created: 2023-10-16 00:59:14 ConfID: 6962649 CauseID: 1593143652 OtherID: 3148 JT: Clinical Genetics MD: Devon,60,2,100,2001,HotSpots DOI: 10.1034/j.1399-0004.2001.600202.2.x(Journal) (6962649-N) DOI: 10.1034/j.1399-0004.2001.6002022.x(Journal) ========================================================== Created: 2023-10-16 00:59:14 ConfID: 6962647 CauseID: 1593143652 OtherID: 3148 JT: Clinical Genetics MD: Devon,60,2,102,2001,HotSpots DOI: 10.1034/j.1399-0004.2001.600202.3.x(Journal) (6962647-N) DOI: 10.1034/j.1399-0004.2001.6002023.x(Journal) ========================================================== Created: 2020-09-09 07:01:21 ConfID: 5657722 CauseID: 1477374665 OtherID: 1477370995 JT: Clinical Genetics MD: ,58,2,156,2000,Errata DOI: 10.1034/j.1399-0004.2000.580213.x(Journal) (5657722-N) DOI: 10.1034/j.1399-0004.2000.580214.x(Journal)